Indian contract research organization (CRO) SIRO Clinpharm is partnering with South Korean CRO DreamCIS to expand SIRO’s services in the Asia-Pacific region.

The two CROs will offer clinical trial management, medical writing, feasibility and patient planning, pharmacovigilance, post marketing surveillance, data management, biostatistics and quality assurance services to clients in South Korea and worldwide. The specific terms of the alliance were not made public.

"We are one of the leading and fastest growing CROs in South Korea. However, looking at the increasing number of global clinical trials and the rapid growth in the Asian clinical trials market, we were looking at associating ourselves with a CRO having a global exposure; not only from business vertical perspective but also from the perspective of moving up on the learning curve. I think our mutually beneficial alliance with SIRO is a definite step in this direction," said DreamCIS president Won-Jung Choi in a statement.

SIRO Clinpharm has offices in India, Israel, Europe and the U.S. The company formed a similar alliance with regulatory services firm Cambridge Regulatory Services last fall to provide regulatory expertise to clients conducting clinical trials in Europe.